ERBB2 and invasive breast carcinoma: CAFs negative for CD146 foster the upregulation and activation of several tyrosine kinase receptors (TKRs), such as EGFR, HER2 and insulin-like growth factor receptor (IGF1R), and the inhibition of ER in BrCa cells which leads to tamoxifen resistance [85].